When the Oncology Care Model (OCM) was coming to an end, there was much excitement around its replacement model, the Enhancing Oncology Model (EOM). Unfortunately, with downside risk being mandatory from the outset, The Center for Medicare and Medicaid Innovation...
CMMI has made an important change to the Enhancing Oncology Model (EOM) for a second enrollment period beginning July 1, 2025 (Performance Period 4). The change resets the neutral zone between the benchmark and target price, rather than at 98% of the benchmark. This...
EOM Participants must take downside risk for all performance periods. They will choose from one of two risk arrangement (RA) options: RA 1: To qualify for savings, participants must reduce expenditures by more than 4% off the benchmark (96% of the benchmark, or the...
5 Year Model; 6-Month Performance Periods (“PPs”) Begins 7/2023; Applications Due 9/30/22 Total cost of care (TCC) model, available to practices and payors. 7 Cancers: Breast, Chronic Leukemia, Small Intestine/ Colorectal, Lung, Lymphoma, Multiple Myeloma, Prostate....
